Yuki Hasegawa

Director/Board Member at NANO MRNA CO.,LTD.

46 year

Health Technology

Finance

Technology Services

Profile

Yuki Hasegawa currently works at ActualEyes, Inc., as Director, NANO MRNA Co., Ltd., as Outside Director from 2021, and Whiz Partners, Inc., as Head-Healthcare Investment from 2021.

Yuki Hasegawa active positions

Companies	Position	Start
NANO MRNA CO.,LTD.	Director/Board Member	2021-05-31
Whiz Partners, Inc. Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010.	Private Equity Investor	2020-12-31
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Director/Board Member	-

All active positions of Yuki Hasegawa

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yuki Hasegawa's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NANO MRNA CO.,LTD.	Health Technology

Private companies	2
Whiz Partners, Inc. Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010.	Finance
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Technology Services